我要投票 沂蒙在玻璃胶行业中的票数:615
· 外 推 电 报 ·
2026-01-11 01:02:21 星期日

【沂蒙是哪个国家的品牌?】

沂蒙是什么牌子?「沂蒙」是 山东省药用玻璃股份有限公司 旗下著名品牌。该品牌发源于山东省淄博市,由创始人扈永在1993-11-08期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力沂蒙品牌出海!将品牌入驻外推网,定制沂蒙品牌推广信息,可以显著提高沂蒙产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

山东省药用玻璃股份有限公司位于山东省沂源县城,这里是中国药用玻璃工业发源地之一,也是中国玻璃工业发达的地区。

山东省药用玻璃股份有限公司创立于1970年,以医药、食品、日用品行业为服务对象,生产各种药用、食品、日用品包装材料。2002年1月24日经中国证监会核准发行3200万股A股,并于2002年6月3日挂牌交易。

经过近40年的奋力拼搏,使山东药玻一步步成长为闻名世界的药用包装行业企业,产品市场覆盖32个省、市、自治区,并远销欧、美、俄、日、韩、东南亚等60多个国家和地区,每年为制药、食品、化妆工业提供百亿支各种规格的包装产品,这些产品中有模制抗生素瓶系列产品、管制瓶系列产品、棕色瓶系列产品、中性硼硅玻璃系列产品、输液瓶系列产品、日化瓶系列产品、食品瓶瓷砖 系列产品、丁基橡胶塞系列产品、预灌封注射器系列产品、铝塑盖系列产品、塑料瓶系列产品等,适用于制药工业粉针、水针、输液、口服液、冻干、生物制剂、片剂等不同药品制剂及食品、化妆品的包装需要,并有各种材质、瓶型及规格可供选择。其中公司的主导产品模制抗生素瓶年产量达90多亿支,药用丁基橡胶塞年产量48亿支,销往国内外各制药企业。

此外,山东药玻不断加大投入,采用最新科技,提高制造系列的自动化程度,完善生产工艺和质量控制手段,开发新的品种。引进了美国艾姆哈特行列式制瓶机生产线,实现了产品的自动检验和自动包装,提高了玻璃制品的成品率。强大的技术开发能力,不断满足用户的新需求成为可能。公司已现有科技成果172项,专利技术49项。

积40年从事药用玻璃制造的丰富经验和雄厚实力,山东药玻建立了完善的质量保证体系,对玻璃制造的每一个环节进行了严格的控制,在同行业中率先通过质量体系认证、环境体系认证和安全体系认证,并始终持续的改进保证体系,提升产品的品质,从而取得了和医药工业良好的配合,赢得了医药界人士的认可和赞赏。

英文翻译:Shandong Pharmaceutical Glass Co., Ltd. is located in Yiyuan County, Shandong Province, which is one of the birthplaces of China's pharmaceutical glass industry and the developed area of China's glass industry. Shandong Pharmaceutical Glass Co., Ltd. was founded in 1970, with the pharmaceutical, food, daily necessities industry as the service object, to produce a variety of pharmaceutical, food, daily necessities packaging materials. On January 24, 2002, China Securities Regulatory Commission approved the issuance of 32 million a shares, which was listed for trading on June 3, 2002. After nearly 40 years of hard work, Shandong Pharmaceutical glass has gradually grown into a world-famous pharmaceutical packaging industry enterprise. Its product market covers 32 provinces, cities and autonomous regions, and is exported to more than 60 countries and regions such as Europe, the United States, Russia, Japan, South Korea, Southeast Asia, etc. every year, it provides tens of billions of packaging products of various specifications for pharmaceutical, food and cosmetic industries, among which there are model antibiotics Bottle series products, control bottle series products, brown bottle series products, neutral borosilicate glass series products, infusion bottle series products, daily chemical bottle series products, food bottle ceramic tile series products, butyl rubber plug series products, pre filling syringe series products, aluminum plastic cover series products, plastic bottle series products, etc., suitable for powder injection, water injection, infusion, oral liquid in pharmaceutical industry , freeze-drying, biological agents, tablets and other different pharmaceutical preparations, food and cosmetics packaging needs, and a variety of materials, bottle types and specifications to choose from. Among them, the annual output of the company's leading product molding antibiotic bottles is more than 9 billion, and the annual output of medical butyl rubber plugs is 4.8 billion, which are sold to various pharmaceutical enterprises at home and abroad. In addition, Shandong Pharmaceutical glass has continuously increased investment, adopted the latest technology, improved the automation level of manufacturing series, improved production process and quality control means, and developed new varieties. The production line of American Emhart determinant bottle making machine is introduced to realize the automatic inspection and packaging of products and improve the yield of glass products. It is possible to continuously meet the new needs of users with powerful technology development capabilities. The company has 172 scientific and technological achievements and 49 patented technologies. With 40 years of rich experience and strong strength in pharmaceutical glass manufacturing, Shandong Pharmaceutical glass has established a perfect quality assurance system, strictly controlled every link of glass manufacturing, took the lead in the industry in passing the quality system certification, environmental system certification and safety system certification, and constantly improved the assurance system to improve the quality of products, so as to achieve and The good cooperation of the pharmaceutical industry has won the recognition and appreciation of the people in the pharmaceutical industry.

本文链接: https://www.waitui.com/brand/3548a554a.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

马斯克透露特斯拉有大约15万员工,持H-1B签证者不到3000人

一位网友分享美国科技公司雇佣持H-1B签证员工数量的图表,显示特斯拉(445.01, 9.21, 2.11%)雇佣着2908名此类员工,并敦促马斯克在特斯拉裁减持H-1B签证员工的数量。马斯克回应称:“我们这样做绝不是为了省钱。而是为了聘请那些具备专业技能的杰出人才加入我们的团队,而且是以高成本。此外,我们有15万名员工,所以这只是百分之几。”(新浪财经)

2小时前

雷军:特斯拉确实强,但并非不可战胜

36氪获悉,1月10日,雷军发文称:“看了易车网销量排行榜:特斯拉确实强,但并非不可战胜!我自豪的是,SU7是迄今为止唯一击败Model 3 的同档纯电轿车!出色的产品力和品质,才会有这样的销量。小米YU7,上市仅6个月时间,销量和Model Y 有差距。我相信,假以时日,YU7 也能一较高下!”

2小时前

外资开年频频加仓中国资产

据上证报,2026年伊始,外资机构对中国资产的配置热情持续升温。记者在港交所披露易检索发现,自2026年1月1日以来,摩根大通在港股密集增持宁德时代、赣锋锂业、信达生物等H股公司,涵盖新能源、生物医药、通信服务等多个领域。“这种现象反映出国际资本对中国经济企稳回升的预期增强,以及港股估值洼地的吸引力凸显,预计2026年内外资机构频频增持的趋势将持续。”一位投行人士对记者表示。此外,2026年以来,景顺中国科技ETF、锐联中国科技创新ETF等多只在美国上市的中国科技类ETF持续吸引资金流入。多家外资巨头认为,中国科技产业长期成长逻辑稳固,中国科技股行情有望在2026年延续。

2小时前

我国科学家创出全新计算架构提升算力

“傅里叶变换”是频率的“翻译器”,可将声音、图像等复杂信号转换为频率语言,是科学和工程领域一种基础且应用广泛的计算方式。北京大学研究团队创出一种全新的多物理域融合计算架构,可利用后摩尔新器件支持傅里叶变换,使算力提升近4倍,为具身智能、边缘感知、类脑计算、通信系统等领域开辟新的可能。该成果9日发表于《自然-电子学》。(新华社)

2小时前

美国联邦通信委员会批准SpaceX再部署7500颗星链卫星

当地时间1月9日,美国联邦通信委员会(FCC)向SpaceX授予重大授权。根据该授权,SpaceX获准建造、部署并运营额外7,500颗第二代星链卫星,使全球卫星总数达到15,000颗。(界面新闻)

2小时前

本页详细列出关于沂蒙的品牌信息,含品牌所属公司介绍,沂蒙所处行业的品牌地位及优势。
咨询